The yeast Saccharomyces cerevisiae from koumiss has been shown to have antibacterial effects on Escherichia coli, possibly by producing antibacterial compound in metabolism; however, there is limited knowledge about its application in animal production. We therefore investigated the effects of an antibacterial compound of S. cerevisiae from koumiss on the immune function and caecal microflora of mice challenged with pathogenic Escherichia coli O8. Three groups were formed: negative control (NC), positive control (PC), and the antibacterial compound of S. cerevisiae at pH 2.0 (S2). Mice in the NC and PC groups were orally administered phosphate buffer solution (PBS) for 7 d. At 4 d, E. coli O8 was administered intraperitoneally in group PC. Mice in group S2 were first administered orally as mice in group NC, and subsequently intraperitoneally administered E. coli O8 as mice in group PC. Compared with the NC group, mice in the PC group displayed clinical symptoms and pathological changes in the small intestine. Small intestine villi in the S2 group also developed some histologically pathological changes but not as severe as in the PC group. Moreover, there was less mortality in the S2 group than in the PC group. In PC group, thymus indexes, immunoglobulin A (IgA) in serum and Bifidobacterium in caecum were decreased and E. coli in the caecum was increased. In the S2 group, CD8+ of T lymphocyte subsets in blood and Bifidobacterium in caecum were decreased, while spleen indexes, IgG, IgM in serum, and CD3+ of T lymphocyte subsets in blood were increased. This suggests that S2 can relieve clinical symptoms of mice challenged with pathogenic E. coli O8, enhance their immune function, and influence their caecal microflora. The study will provide a theoretical foundation for utilizing antibacterial compound of S. cerevisiae from koumiss for curative purposes.
Pathogenic E. coli are common pathogens in animal husbandry. Clinical symptoms and pathological changes of various animals after infection differ. For example, pathogenic E. coli often result in diarrhea in calves, leading to high morbidity and mortality. Carriers of pathogenic E. coli are the sources of infection; their excreta contact the feed, water, grassland, resulting in enormous economic losses for the breeding industry (Boerlin et al. 1999; Gow et al. 2008; Mainda et al. 2015) .
Antibiotics are used in calves in treating diarrhea due to pathogenic E. coli, but excessive use and abuse of antibiotics results in drug resistance of many pathogenic E. coli; moreover, antibiotic residues in animals may endanger human health and safety (Cizman 2003; Levy and Marshall 2004; Tadesse et al. 2012; Dwivedi et al. 2015) . Therefore, new alternative methods to treat or prevent E. coli infections, such as probiotics from koumiss, are being investigated. In our previous study, we isolated many pathogenic E. coli from calve rectum faeces in the Hulunbeier area of Inner Mongolia, China. Among these strains, E. coli O8 was the dominant pathogenic strain (Simujide et al. 2012 ). In addition, we found that an antibacterial compound of S. cerevisiae from koumiss could inhibit the growth of pathogenic E. coli O8 in vitro (Chen et al. 2015) . It is expected to become a new antibiotic substitute. Hence, in the present study, mice were orally administered the antibacterial compound of S. cerevisiae by gavage, and comparative experiments were conducted after mice were challenged with pathogenic E. coli O8. The effects of the antibacterial compound of S. cerevisiae from koumiss on the immune function and caecal microflora of mice challenged with pathogenic E. coli O8 were determined. The study provides a theoretical foundation for utilizing the antibacterial compound of S. cerevisiae from koumiss in practice.
Materials and Methods

Reagents and strains
The reagents and strains used were as follows: Potato dextrose (PD) liquid medium (BD, NewYork, USA). Antibodies: monoclonal rat anti-mouse CD3:fluorescein isothiocyanate (FITC) (11-0032), monoclonal rat anti-mouse CD4:phycoerythrin (PE) (12-0041), monoclonal rat anti-mouse CD8:PE (12-0081), monoclonal rat anti-mouse CD19:FITC (11-0193) (Affymetrix, California, USA). Escherichia coli O8: the dominant pathogenic E. coli isolated from calve rectum faeces in the Hulunbeier area of Inner Mongolia, China (Simujide et al. 2012) . The virulence gene of E. coli O8 was eaeA and classified as atypical enteropathogenic E. coli (EPEC). Escherichia coli O8 was thawed, subcultured onto a nutrient broth medium (BD, New York, USA), and harvested following 24 h of incubation at 37 °C. The growth phase was a log phase according to its growth curve (Chen et al. 2017) .
Saccharomyces cerevisiae: the major yeast isolated and identified in koumiss samples collected from the Hulunbeier area was grown in PD liquid medium (potato 300 g/l, dextrose 20 g/l, chloramphenicol 0.1 g/l), and harvested following a 72 h incubation at 25 °C. The culture solution was filtered, then the antibacterial compound of S. cerevisiae was extracted by ethyl acetate at pH 2.0, according to Chen et al. (2015) (S2). The main components were found to be citric (6 595.90 mg/100 g), ascorbic (1 157.53 mg/100 g), lactic (971.03 mg/100 g), malic (778.12 mg/100 g), and formic (768.27 mg/100 g) acids, and killer toxin (70.99 mg/100 g) (Chen et al. 2017 ).
Animal and experimental design
A total of 96 mice of the Kunming strain obtained from the Animal Centre of Inner Mongolia University, Hohhot, China, weighing 18-22 g were randomly divided into 3 groups of 32 mice each. The experimental design is presented in Table 1 (Chen et al. 2015) . Mice in each group were reared in conventional cages (545 × 395 × 200 mm) with sawdust maintained at a constant temperature (22 ± 1 °C) with a 12-h light/dark cycle. Pellets of mice food without antibiotic (provided by the Animal Centre of Inner Mongolia University, Hohhot, China) were given to the mice with fresh water ad libitum. The mice were acclimatized for 2-3 days in the environment where the experiments were conducted. The animal protocol, experimental design and procedures were approved by the Inner Mongolia Agricultural University, Hohhot, China.
Clinical observation and histological analysis
The mice were monitored daily for survival and well-being status (body condition, mental state, mobility and other general conditions) (Burkholder et al. 2012) . At days 0, 4, and 7, eight mice of each group were sacrificed by cervical dislocation and blood was collected by cardiac puncture. Small intestine samples were fixed in a 4% buffered formalin solution, dehydrated, cleared, embedded in paraffin, cut into 5 μm thick sections, stained by haematoxylin and eosin (HE), and taken for histological analysis (Generoso et al. 2010) .
Immunoglobulin determination
Some blood was allowed to clot at room temperature for 1 h before being centrifuged at 1 500 r/min at 5 °C for 10 min. The serum was collected and stored in aliquots at -20 °C. Enzyme-linked immunosorbent assay (ELISA) kits (Boerdi, Nanjing, China) were used according to the manufacturer's protocol for determination of immunoglobulins A (IgA), G (IgG), and M (IgM) (L e e et al. 2006 ).
Lymphocyte subsets Assay
Blood was also collected in anticoagulative tubes. Aliquots of 200 μl blood were added to 5 ml haemolysin at × 10 dilution, shaken, left to stand for 12 min, then centrifuged (310 × g, 7 min). Lymphocyte sediments were washed with PBS × 3 and suspended in 100 μl PBS at a concentration of 1 × 10 6 cells/μl. Lymphocyte suspensions were divided into two 50 μl parts and transferred into a polystyrene round-bottom tube. Monoclonal rat anti-mouse CD3:FITC/CD8:PE, and monoclonal rat anti-mouse CD4:PE/CD19:FITC were added to the respective tubes. The sample was gently mixed and incubated at 4 °C for 30 min, and then centrifuged (310 × g, 7 min). Lymphocytes were suspended in 300 μl PBS, and then analyzed by Facsealibur flow cytometer (Becton, Dickinson and Company, NewYork, USA). Lymphocyte percentages and CD4+/CD8+ were determined and calculated.
Thymus and spleen index assay
Thymus and spleen were quickly removed. Weighed indexes were calculated as follows: thymus index = thymus weight/body weight; spleen index = spleen weight/body weight (Guo et al. 2012 ).
Caecal microflora determination
Mice caecum was weighed and digesta aseptically collected in sterilized tubes, gradient diluted × 10 with sterile saline to obtain 10 -1 -10 -8 multiple of the original solution. Then aliquots of 50 µl of each dilute solution were spread onto each BBL agar (selective culture medium of Bifidobacteria), LBS agar (selective culture medium of Lactobacilli), DHL agar (selective culture medium of E. coli), KF agar (selective culture medium of Enterococcus) and incubated as follows: after 48 h incubation at 37 °C under anaerobic conditions, Bifidobacteria colonies grown on BBL were round, raised, and creamy with neat and smooth edge; after 48 h incubation at 37 °C in anaerobic condition, Lactobacilli colonies grown on LBS agar were white and raised; after 24 h incubation at 37 °C, E. coli colonies grown on DHL agar were peach coloured; after 48 h incubationat 37°C, Enterococcus colonies on KF agar were darkled and shiny with a neat edge. All bacteriological media were supplied by Hope Bio-Technology co., LTD, Qingdao, China. When the colonies appeared, appropriate dilutions were selected for counting. The visible counts per gram of caecum digesta were calculated and expressed as follows: caecal microflora counts (lg cfu/g) = lg [X/0.05 × dilution times/caecum digesta (g)], where X equals the visible counts in the appropriate dilutions.
Statistical analysis
All data were expressed as mean ± standard deviation (SD). Differences between groups were evaluated by one-way analysis of variance (ANOVA) of SAS following a complete random design, with the group used as the experimental unit for analysis. When the system treatment was significant (P < 0.05), the means were compared using Duncan's multiple comparison procedure.
Results
Clinical symptoms and histology of pathological changes
Mice in the NC group had no obvious changes. After being challenged with E. coli O8 for 0.5 d, some mice in the PC group showed signs of depression and clustering. After being challenged with E. coli O8 for 1-1.5 d, mice in the PC group had obvious changes: narrowed eyes, diarrhoea, anorexia, depression, slow movement, clustering, and some mortality. After being challenged with E. coli O8 for 2-3 d, the number of dead mice in the PC group increased, but the surviving mice were more vigorous and nimble than before. The number of dead mice in the S2 group was lower than in the PC group, and the eyes of the mice in the S2 group were brighter, and the mice showed more vigorous and nimble activity than those in the PC group (Table 2) .
Intestinal villi of mice in the NC group were aligned and slender (Plate XI, Fig. 1 ). The small intestines of mice in the PC group exhibited histologically pathological changes, shortened intestinal villi, wider intervillous spaces compared to the NC group, with some villi broken off. Intestinal villi in the S2 group were more slender compared to the NC group at 4 d and they also showed fewer histologically pathological changes at 7 d compared to the PC group. These results demonstrate that a challenge with E. coli O8 results in changes in the small intestine which can be reversed as in the S2 treatment.
Immunoglobulins
IgA in the PC group was significantly lower than in the NC group at 7 d (P < 0.05) (Table 3) . IgA, IgG, and IgM in the S2 group were significantly higher than in the NC group at 4 d (P < 0.05). IgG and IgM in the S2 group was significantly higher than in the NC group at 7 d (P < 0.05). This suggests that the IgA decreased after mice were challenged with E. coli O8 but S2 could reverse this phenomenon.
Lymphocyte subsets CD3+ of mice in the S2 group was significantly higher than in the NC group at 7 d (P < 0.05) (Table 4 , Plate XI, Fig. 2 ). CD8+ of mice in the S2 group was significantly Thymus and spleen indexes Thymus indexes of mice in the PC group were significantly lower than in the NC group at 7 d (P < 0.05) ( Table 5 ). Spleen indexes of mice in the S2 group were significantly higher than in the NC group at 7 d (P < 0.05). This suggests that thymus indexes decrease after mice are challenged with E. coli O8, but S2 could reverse this phenomenon.
Caecal microflora
E. coli in the PC group were significantly higher than in the NC group at 7 d (P < 0.05), and Bifidobacteria were significant lower. Bifidobacteria in the S2 group were significant lower than in the NC group at 7 d (P < 0.05) (Table 6 ). This suggests that E. coli increase and Values with different lowercase superscripts in the same row mean a significant difference (P < 0.05); values with the same or no superscript mean no significant difference (P > 0.05). NC -negative control, PC -positive control, S2 -antibacterial compound of S. cerevisiae extracted at pH 2.0 Bifidobacteria decrease after mice are challenged with E. coli O8, but S2 could decrease E. coli and increase Bifidobacteria of mice challenged with E. coli O8.
Discussion
Live yeast (S. cerevisiae) is an important probiotic that has been reported to modulate the intestinal microbial balance (Haldar et al. 2011) , to improve humoral immune responses, intestinal structure, and function of animals (Haldar et al. 2011; Xiong et al. 2015) . Furthermore, live yeast supplementation was shown to mitigate bacteria-associated immunological derangement and intestinal disorders in pigs (Trevisi et al. 2015) and to attenuate pathogen-induced intestinal inflammation in mice (Jawhara et al. 2012) . Similar results were also found in in vitro studies, where treatment with live yeast reduced the expressions of pro-inflammatory cytokines and increased the expressions of antiinflammatory cytokines of porcine intestinal epithelial cells following bacterial invasion (Zanello et al. 2011 ). Nevertheless, a comprehensive understanding of antibacterial compounds produced by yeasts in the metabolism is lacking. Moreover, the physiological activity of yeast is easily affected by the processing technology, storage, culture medium, temperature, pH, internal environment of digestive tract and feeding pattern. So, the stability of yeast is poor yielding unstable effects. The antibacterial compound produced by yeast, on the other hand, may retain its quality and therefore the effect may be stable.
Some yeasts can produce antibacterial substances like organic acids and killer toxins, the variety and quantity depending on the source and species of yeast (Csoma et al. 2010; Lane et al. 2011 ). Koumiss has beneficial effects, therefore, the antibacterial effects of various organic acids and killer toxins contained in antibacterial compounds of S. cerevisiae from koumiss named S2 were studied.
Mice appeared anorexic and exhibited other pathological changes after they were challenged with E. coli O8 in the PC group, similar to the clinical symptoms of mice challenged with E. coli O157:H7 (Fan et al. 2012; Bian et al. 2016) . Bian et al. (2016) found that mice had diarrhoea after they were challenged with E. coli O157:H7, however, Fan et al. (2012) reported that mice had no diarrhoea after they were challenged with Table 6 . Effect of S2 on caecal microflora of mice challenged with pathogenic E. coli O8 (lg CFU/g of caecum E. coli O157:H7. This might be due to the differences of source, serotype, virulence factor, and infection method (injection or gavage) of E. coli. Moreover, we found that the intestinal villi of mice were damaged after they were challenged with E. coli O8. This was consistent with Girard et al. (2008) . But S2 could relieve the clinical symptoms and improve the condition of the small intestine of mice challenged with E. coli O8. A possible mechanism is that S2 could preserve the intestinal mucosal integrity and permeability, which are affected during pathological and infectious episodes.
Immunoglobulins are the primary antibodies mediating humoral immunity; antibody levels in serum reflect to a certain degree the body's resistibility to disease. IgA, IgG, and IgM represent immunoglobulin concentrations in serum (Fan et al. 2012) . The results of our study demonstrated that IgA decreased after the mice were challenged with E. coli O8. However, S2 could increase immunoglobulin levels after mice were challenged with E. coli O8. IgA, IgG, and IgM in the S2 group were significantly higher than in the NC group at 4 d. IgG and IgM in the S2 group were significantly higher than in the NC group at 7 d. It is considered that S2 could relieve clinical symptoms of mice challenged with E. coli O8, recovering some indexes to normal levels. It is suggested that S2 is beneficial to the improving of humoral immune ability of mice challenged with E. coli O8, enhancing the immune function, and inducing anti-inflammatory immune effects.
The T and B lymphocytes participate in cell immunity functions. Levels of CD3+ represent total T cell levels in peripheral lymphoid organs. A decrease in CD3+ signals a reduction of mature T cells, resulting in the decrease of immunity function. T lymphocytes contain CD4+ and CD8+ cells. Higher levels of CD4+ and the value of CD4+/CD8+ within limits demonstrates a better immunity function (Sharpe and Abbas 2006) . CD19+ is a surface antigen of B lymphocytes which is expressed at an early stage, persisting till it differentiates into plasma cells (LeBien and Tedder 2008) . Relatively small changes in CD19 surface expression can lead to a loss of tolerance and autoantibody production (Sato et al. 2004) . The results of our study suggest that S2 could increase CD3+, and decrease CD8+ of mice challenged with E. coli O8. It is considered that S2 is beneficial to increasing the immunity function.
The thymus is the main central immune organ of lymphocyte differentiation and maturation, and the spleen is the most important peripheral lymphoid organ. Lymphocytes develop and mature in the thymus, and then they are transferred to the spleen, lymphoid tissues, and lymphoid organs by the circulatory system to store and play an immunization role. Therefore, weight increments of the thymus and spleen indicate rapid development of immune organs, and increase of thymus and spleen indexes indicates rapid maturation of immune systems (Guo et al. 2012) . The results of our study suggest that thymus indexes of mice decrease after the challenge with E. coli O8. However, S2 could increase thymus and spleen indexes of mice challenged with E. coli O8, which indicates that S2 promotes the growth and development of the thymus and spleen, and improves the immune function of mice.
The flora in the intestinal tract is affected by the diet and the environment. The balance and stability of the intestinal flora are essential conditions determining the animal's health. The caecal microflora directly reflects changes in the intestinal flora. Anaerobes are the main bacteria in the caecum, the predominant species belonging to Bifidobacteria and Lactobacilli. Escherichia coli and Enterococcus are the conditioned pathogens within the caecum. Their numbers reflect the intestinal health (Holzapfel et al. 1998; Hooper and Gordon 2001) . The results of our study suggest that when E. coli increase after mice are challenged with E. coli O8, Bifidobacteria decrease. It is considered that E. coli O8 results in dysbacteriosis in mice. It was similar to the change of intestinal flora after mice were challenged with E. coli O157:H7 (Bian et al. 2016) . S2 could decrease E. coli, increase Bifidobacteria of mice challenged with E. coli O8, suggesting that S2 promotes the growth and colonization of probiotics. In addition, the acetic acid produced by Bifidobacteria and the organic acids in S2 could regulate the pH value of the intestinal tract, inhibit the growth and reproduction of harmful bacteria, maintain normal percentages of caecal microflora, and prevent diseases. S2 may promote a more symbiotic intestinal microflora favouring the host when challenged with an enteric pathogen such as E. coli.
In conclusion, mice challenged with E. coli O8 displayed histologically pathological changes in the small intestine, an increase in E. coli, thymus indexes, and IgA, and a decrease in Bifidobacteria. The culture extract of S. cerevisiae (S2) could relieve and improve small intestine symptoms, increase spleen indexes, IgG, IgM, and CD3+, decrease CD8+ in mice challenged with E. coli O8. So, the S2 can enhance the immune function in mice, and influence their caecal microflora. The study provides a theoretical foundation for utilizing an antibacterial compound of S. cerevisiae from koumiss for therapeutic purposes. 
